Evidence map›Paper›PMID 40657931›Full record

ArticleBrain : a journal of neurology2025

Sleep, pericyte subtypes and cognitive decline in adults with and without Alzheimer's disease.

Mahnoor Hamid, Trishna Saha Detroja, Shreejoy J Tripathy, Vilas Menon, Jishu Xu, Lei Yu, Yanling Wang, Aron S Buchman, David A Bennett, Philip L De Jager and 1 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Eppur si muove: the dynamic brain pericyte.Fluids and barriers of the CNS · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mahnoor HamidDivision of Neurology, Department of Medicine, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada M4N 3M5.ORCID 0009-0003-6446-9115
Trishna Saha DetrojaDivision of Neurology, Department of Medicine, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada M4N 3M5.
Shreejoy J TripathyInstitute of Medical Sciences, University of Toronto, Toronto, ON, Canada M5S 3K3.
Vilas MenonRush Alzheimer Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.
Jishu XuRush Alzheimer Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.
Lei YuRush Alzheimer Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.
Yanling WangRush Alzheimer Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.
Aron S BuchmanRush Alzheimer Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.ORCID 0000-0002-6426-2742
David A BennettRush Alzheimer Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.ORCID 0000-0003-3689-554X
Philip L De JagerCenter for Translational & Computational Neuroimmunology, Columbia University Irving Medical Center, New York, NY 10032, USA.ORCID 0000-0002-8057-2505
Andrew S P LimDivision of Neurology, Department of Medicine, Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada M4N 3M5.

Funding

EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targetsU01AG061356 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2018 to 2022
$13.7M
Alzheimer variants: Propagation of shared functional changes across cellular networksU01AG072572 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE JAGER, PHILIP L, ST GEORGE-HYSLOP, PETER HENRY · 2021 to 2025
$8.5M
Discovery and validation of genetic variants affecting microglial activation in Alzheimer's diseaseRF1AG070438 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE JAGER, PHILIP L · 2020 to 2020
$6.2M
Exploring the Role of the Brain Epigenome: Cognitive Decline and Life ExperiencesRF1AG036042 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2016 to 2016
$5.5M
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro OrganoidsR01AG079223 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Yanling Wang · 2022 to 2026
$3.7M
Uncovering cell-type-specific driver genes of Alzheimer's Disease by pathology-indexing scRNA-seq, spatial transcriptomics, and CRISPR screensR01AG074082 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Yanling Wang · 2022 to 2026
$3.6M
Impaired Gait in Older Adults: Pathologies of Alzheimer's disease and Related DisordersR01AG056352 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BUCHMAN, ARON S · 2017 to 2021
$3.5M
Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human BrainR01AG052488 · NIA · SUNNYBROOK RESEARCH INSTITUTE · PI LIM, ANDREW · 2017 to 2021
$3.3M
Risk Factors and the Neurobiologic Substrate of FrailtyR01AG024480 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BUCHMAN, ARON S · 2005 to 2009
$3.2M
Spinal cord and brainstem pathology contributions to late-life gait impairmentR01AG047976 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BUCHMAN, ARON S · 2015 to 2019
$2.6M
Krembil FoundationNatural Sciences and Engineering Research Council of Canada DGECR-2020-00048Natural Sciences and Engineering Research Council of Canada RGPIN-2020-05834NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01AG017917NIA NIH HHS R01 AG024480NIA NIH HHS R01AG024480NIA NIH HHS R01 AG047976NIA NIH HHS R01AG047976NIA NIH HHS R01 AG048015NIA NIH HHS R01AG048015NIA NIH HHS R01 AG052488NIA NIH HHS R01AG052488NIA NIH HHS R01 AG056352NIA NIH HHS R01AG056352NIA NIH HHS R01 AG070436NIA NIH HHS R01AG070436NIA NIH HHS R01 AG074082NIA NIH HHS R01AG074082NIA NIH HHS R01 AG079223NIA NIH HHS R01AG079223NIA NIH HHS R01AG15819NIA NIH HHS RF1 AG036042NIA NIH HHS RF1AG036042NIA NIH HHS RF1 AG070438NIA NIH HHS RF1AG070438NIA NIH HHS U01 AG061356NIA NIH HHS U01AG061356NIA NIH HHS U01 AG072572NIA NIH HHS U01AG072572Robert C. Borwell Endowment Fund
6 · The paper itself

Abstract

Sleep fragmentation is common in older adults and is associated with cognitive impairment and dementia, as well as key histopathological correlates of dementia, including small vessel disease and cerebral infarcts. Vascular and blood-brain barrier dysfunction are thought to contribute to cognitive decline and dementia. Pericytes, a key vascular cell type, may play a key role. In model organisms, sleep disruption is associated with pericyte dysfunction and blood-brain barrier breakdown. Recent advances in single-nucleus RNA sequencing (snRNAseq) technology have identified two transcriptionally distinct subtypes of pericytes: extracellular matrix protein-expressing M-pericytes and solute carrier-expressing T-pericytes. However, the relationship between sleep, pericyte biology and cognition in humans remains unclear. We tested the hypothesis that differences in the composition of brain pericyte subpopulations, as inferred from marker gene expression, may link sleep fragmentation and cognitive decline. We leveraged two published human brain snRNAseq datasets to identify specific marker genes for M- and T-type pericytes. We then used post-mortem bulk RNAseq data from the dorsolateral prefrontal cortex (n = 1092) and lateral orbitofrontal cortex (n = 495) to quantify expression of these marker genes in older adults in two longitudinal cohort studies: the Religious Orders Study and Rush Memory and Aging Project. We derived trajectories of global cognitive function from participants' ante-mortem annual cognitive assessments, while sleep fragmentation was derived from ante-mortem wrist-actigraphy recordings from a subset of 572 participants. We used multivariate linear regression to relate pericyte marker gene expression to sleep fragmentation and cognitive decline in the decade preceding death. In the dorsolateral prefrontal cortex, greater average sleep fragmentation was associated with greater expression of M-pericyte marker genes [estimate = +3.65 × 10-1, standard error (SE) = 1.61 × 10-1, P = 0.024] but not T-pericyte marker genes. Dorsolateral prefrontal cortex expression of M-pericyte (estimate = -8.30 × 10-3, SE = 3.37 × 10-3, P = 0.014) but not T-pericyte marker genes was associated with more rapid cognitive decline in the 10 years prior to death. In the lateral orbitofrontal cortex, greater sleep fragmentation was also associated with greater composite M-pericyte gene expression (estimate = + 4.48 × 10-1, SE = 1.92 × 10-1, P = 0.02), which in turn was associated with faster cognitive decline in the decade preceding death (estimate = -1.30 × 10-2, SE = 4.55 × 10-3, P = 0.0044). These findings identify a potential role of M-pericytes in linking sleep fragmentation and cognitive trajectories in older adults. Additionally, our findings highlight the importance of vascular mechanisms in linking disrupted sleep to dementia.

Indexed as

Alzheimer DiseaseCognitive DysfunctionPericytesSleepSleep DeprivationAgedAged, 80 and overFemaleHumansMalePrefrontal Cortexactigraphyagingcerebral small vessel diseasecognitive declinesleep fragmentation

Identifiers

PMID40657931
PMCPMC12404711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.